Fomivirsen sodium

DRUG4 trials

Sponsors

Ionis Pharmaceuticals, Inc.

Conditions

Cytomegalovirus RetinitisHIV Infections

Phase 2

The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes

CompletedNCT00002356

Ionis Pharmaceuticals, Inc.Cytomegalovirus Retinitis, HIV Infections

Updated: 2005-06-24

A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )

CompletedNCT00002156

Ionis Pharmaceuticals, Inc.Cytomegalovirus Retinitis, HIV Infections

Target: 194Updated: 2005-06-24

Unknown Phase

A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes

CompletedNCT00002355

Ionis Pharmaceuticals, Inc.Cytomegalovirus Retinitis, HIV Infections

Target: 60Updated: 2005-06-24

A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

CompletedNCT00002187

Ionis Pharmaceuticals, Inc.Cytomegalovirus Retinitis, HIV Infections

Updated: 2005-06-24